Business Description
Shanghai Hile Bio-Technology Co Ltd
ISIN : CNE1000022T4
Share Class Description:
SHSE:603718: Class ATotal Employee Number:
340Compare
Compare
Traded in other countries / regions
603718.China Index Membership
SSE Composite Index IPO Date
2015-05-15Description
Shanghai Hile Bio-Technology Co Ltd is engaged in Research, development, and production of human in vitro diagnostic reagents, as well as research, development, production, and sales of animal biological products and oral tissue repair and regeneration materials.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.26 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.1 | |||||
Debt-to-EBITDA | -0.47 | |||||
Interest Coverage | 43.37 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.37 | |||||
Beneish M-Score | -4.52 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -15.4 | |||||
3-Year FCF Growth Rate | -45.3 | |||||
3-Year Book Growth Rate | -8.8 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 63.72 | |||||
9-Day RSI | 55.26 | |||||
14-Day RSI | 50.2 | |||||
3-1 Month Momentum % | -32.05 | |||||
6-1 Month Momentum % | -59.17 | |||||
12-1 Month Momentum % | -64.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.27 | |||||
Quick Ratio | 3.76 | |||||
Cash Ratio | 2.8 | |||||
Days Inventory | 418.7 | |||||
Days Sales Outstanding | 233.51 | |||||
Days Payable | 72.26 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.74 | |||||
Dividend Payout Ratio | 0.38 | |||||
5-Year Yield-on-Cost % | 2.85 | |||||
3-Year Average Share Buyback Ratio | -0.6 | |||||
Shareholder Yield % | 3.29 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 68.77 | |||||
Operating Margin % | 22 | |||||
Net Margin % | -182.17 | |||||
EBITDA Margin % | -112.09 | |||||
FCF Margin % | 34.1 | |||||
OCF Margin % | 39.27 | |||||
ROE % | -24.45 | |||||
ROA % | -20.12 | |||||
ROIC % | 3.69 | |||||
3-Year ROIIC % | 3.13 | |||||
ROC (Joel Greenblatt) % | -119.65 | |||||
ROCE % | -13.22 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio without NRI | 13.82 | |||||
Shiller PE Ratio | 57.2 | |||||
PS Ratio | 11.36 | |||||
PB Ratio | 2.1 | |||||
Price-to-Tangible-Book | 4.69 | |||||
Price-to-Free-Cash-Flow | 35.76 | |||||
Price-to-Operating-Cash-Flow | 31.11 | |||||
EV-to-EBIT | -8.55 | |||||
EV-to-EBITDA | -8.55 | |||||
EV-to-Revenue | 9.59 | |||||
EV-to-FCF | 28.11 | |||||
Price-to-GF-Value | 0.67 | |||||
Price-to-Projected-FCF | 1.25 | |||||
Price-to-Median-PS-Value | 0.49 | |||||
Price-to-Graham-Number | 1.7 | |||||
| Price-to-Net-Current-Asset-Value | 8.17 | |||||
| Price-to-Net-Cash | 71.5 | |||||
Earnings Yield (Greenblatt) % | -11.7 | |||||
FCF Yield % | 3.17 | |||||
Forward Rate of Return (Yacktman) % | -23.78 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Hile Bio-Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 173.466 | ||
| EPS (TTM) (Â¥) | -0.49 | ||
| Beta | 0.5474 | ||
| 3-Year Sharpe Ratio | -1.14 | ||
| 3-Year Sortino Ratio | -1.19 | ||
| Volatility % | 37.27 | ||
| 14-Day RSI | 50.2 | ||
| 14-Day ATR (Â¥) | 0.130478 | ||
| 20-Day SMA (Â¥) | 2.795 | ||
| 12-1 Month Momentum % | -64.24 | ||
| 52-Week Range (Â¥) | 2.57 - 7.81 | ||
| Shares Outstanding (Mil) | 651.9 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Hile Bio-Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Hile Bio-Technology Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.078400 Cash Dividend | 2025-07-15 | 7.62 (-0.26%) | ||
| 2.3:1 Stock Split | 2016-05-05 | 19.04 (+1.88%) |
Show
Entries
Shanghai Hile Bio-Technology Co Ltd Frequently Asked Questions
What is Shanghai Hile Bio-Technology Co Ltd(SHSE:603718)'s stock price today?
The current price of SHSE:603718 is ¥2.86. The 52 week high of SHSE:603718 is ¥7.81 and 52 week low is ¥2.57.
When is next earnings date of Shanghai Hile Bio-Technology Co Ltd(SHSE:603718)?
The next earnings date of Shanghai Hile Bio-Technology Co Ltd(SHSE:603718) is .
Does Shanghai Hile Bio-Technology Co Ltd(SHSE:603718) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Hile Bio-Technology Co Ltd(SHSE:603718) is 2.74% (As of Today), Highest Dividend Payout Ratio of Shanghai Hile Bio-Technology Co Ltd(SHSE:603718) was 5.5. The lowest was 0.1. And the median was 0.55. The  Forward Dividend Yield % of Shanghai Hile Bio-Technology Co Ltd(SHSE:603718) is 0%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Shanghai Hile Bio-Technology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers